Loading...
Market
Novo Nordisk creates 1,000 jobs at new facility by Dec 31, 2024?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcement from Novo Nordisk or relevant local government agencies
Story
Novo Nordisk to Invest $4.1 Billion in North Carolina Facility, Creating 1,000 Jobs to Boost Wegovy, Ozempic Production
Jun 24, 2024, 06:29 PM
Novo Nordisk has announced a $4.1 billion investment to build a new manufacturing facility in North Carolina. The facility will focus on increasing the production of its popular weight-loss treatment Wegovy and diabetes drug Ozempic. This expansion is part of a broader strategy to bolster its U.S. manufacturing capabilities, with a total investment of $6.8 billion by 2024. The new plant in Clayton, North Carolina, is expected to create over 1,000 new jobs. The move comes amid rising discontent in the U.S. over the high cost of these drugs, with figures like Senator Bernie Sanders criticizing the price disparity between the U.S. and other countries.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 10,000 units per month • 25%
10,000 to 50,000 units per month • 25%
50,001 to 100,000 units per month • 25%
More than 100,000 units per month • 25%
Yes • 50%
No • 50%
Less than 500 • 25%
500 to 999 • 25%
1000 to 1499 • 25%
1500 or more • 25%
New weight-loss drug • 25%
New diabetes drug • 25%
New cardiovascular drug • 25%
Other • 25%